1. Home
  2. MNOV vs SLNG Comparison

MNOV vs SLNG Comparison

Compare MNOV & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.39

Market Cap

69.4M

Sector

Health Care

ML Signal

HOLD

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$3.92

Market Cap

103.2M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNOV
SLNG
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
69.4M
103.2M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
MNOV
SLNG
Price
$1.39
$3.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$7.50
$10.00
AVG Volume (30 Days)
17.4K
24.2K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2400.00
EPS
N/A
N/A
Revenue
$2,360,807.00
$68,245,000.00
Revenue This Year
N/A
$8.66
Revenue Next Year
$180.00
$14.31
P/E Ratio
N/A
N/A
Revenue Growth
194.15
N/A
52 Week Low
$1.17
$3.21
52 Week High
$1.96
$6.36

Technical Indicators

Market Signals
Indicator
MNOV
SLNG
Relative Strength Index (RSI) 46.91 48.53
Support Level $1.35 $3.25
Resistance Level $1.43 $4.90
Average True Range (ATR) 0.03 0.31
MACD -0.00 -0.01
Stochastic Oscillator 24.00 44.41

Price Performance

Historical Comparison
MNOV
SLNG

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: